HIV

The behavioral economic biases of 43 African American young adults aged 18 to 24 were evaluated on 4 fronts: present bias, information salience, overoptimism, and loss aversion.

In a cohort of patients in New York with mpox, HIV status did not seem to affect treatment outcomes with tecovirimat, although more research is needed.

A recent study found that HIV is 2.5 times more common in people who use mental health services compared with the general population in South London.

In the first 2 years after receiving an HIV diagnosis, people with HIV were about 3 times more likely to develop depression, use antidepressants, and undergo electroconvulsive therapy—and 10 times more likely to commit suicide—compared with people without HIV.

HIV infection was more common among those who died of mpox compared with survivors, with an HIV prevalence of 93.9% and 38.3%, respectively, based on available information.

According to interim results from the REPRIEVE study, individuals with HIV who took the daily statin experienced a 35% reduced risk of major adverse cardiovascular (CVD) events, compared with those who received a placebo.

A test using a single spot of dried blood successfully detected HIV, hepatitis B, and hepatitis C in all 60 samples with known amounts of each virus.

Participants with HIV who inject drugs were more likely to initiate antiretroviral therapy and utilize substance use care after participating in group stigma-coping sessions, compared with those who received usual services.

Research showed that HIV incidence and mortality rates were highest among transgender women who were Black or Latinx or lived in the southern United States.

The ruling does not completely get rid of all preventive services coverage under the Affordable Care Act; it only applies to updates or new recommendations made by the US Preventative Services Task Force since March 2010.

The ruling of Braidwood Management v Becerra puts HIV pre-exposure prophylaxis (PrEP) coverage at risk, potentially leading to more than 2000 preventable HIV infections in the coming year.

Similar to findings among young adults, children with HIV in Tanzania were found to have lower distortion product otoacoustic emissions (DPOAEs) and auditory brainstem responses (ABR) wave V amplitudes, compared with children without HIV.

The patient, referred to as the “New York patient,” was treated with stem cells from cord blood, and has remained HIV-free in her blood since her transplant in 2017.

Study results indicates that the injectable antiretroviral therapy can benefit patients who are historically underserved and may face treatment barriers, including those with mental illness.

Since 2004, the number of individuals with HIV receiving antiretroviral therapy (ART) has increased 300-fold through the US President’s Emergency Plan for AIDS Relief (PEPFAR).

Body mass index and nadir CD4 count were major factors in SARS-CoV-2 humoral immune repertoire among people with HIV.

Researchers found that only 8 of 18 HIV risk assessment models have been externally validated and show moderate-to-good discrimination ability for HIV infection prediction.

Therapy adjustments in MDR HIV are explored by Dr Sension.

Optimized background regimens are highlighted in the treatment approach for MDR HIV by Michael Sension, MD.

The study also showed, despite an existing association between discrimination based on sexual orientation and HIV pre-exposure prophylaxis (PrEP) use, increased resilience reduced the effects of such discrimination on PrEP use.

The 3 companies announced a partnership to provide free, same-day prescription delivery of HIV pre-exposure prophylaxis (PrEP) and antiretroviral medications.

Dr Haumschild leads a discussion highlighting goals of therapy and social determinants of health affecting MDR HIV diagnosis and treatment.

A panel of experts explore burdens impacting patients diagnosed with MDR HIV.

A global case series described a severe form of mpox linked to a 15% mortality rate among people living with HIV and low CD4 counts.

Michael Sension, MD, provides insights on resistance mechanisms promoting MDR HIV.

Ryan Haumschild, PharmD, MS, MBA, opens a panel discussion surrounding the incidence and prevalence of multidrug-resistant (MDR) HIV.

A fifth person has been cured of HIV following a stem cell transplant for cancer; a new study examining a treatment of spinal cord stimulation after stroke had favorable results; some food companies enraged by proposed FDA healthy food guidelines.

An HIV prevention and treatment program implemented in Zambian criminal justice facilities demonstrated high levels of pre-exposure prophylaxis (PrEP) uptake among at-risk individuals.

Interviews with 2241 men who have sex with men (MSM) without HIV showed high levels of HIV testing, but lower levels of preventative treatment in 2021.

Biden’s State of the Union (SOTU) address emphasized drug access for those on Medicare, the Cancer Moonshot, and more; HIV diagnoses are increasing in Washington, DC, from missed wellness visits and preventive visits upended during the start of COVID-19; California online women’s pharmacy The Pill Club will pay $18.3 million in Medicaid fraud settlement with California.